GRAIL Inc. (GRAL) vs Hims & Hers Health, Inc. (HIMS)
A side-by-side comparison of GRAIL Inc. and Hims & Hers Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GRAL
GRAIL Inc.
$141.22HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
HIMS
Hims & Hers Health, Inc.
$29.56HealthcareDelayed quote: Oct 6, 2026, 11:10 AM EDT
Total return — GRAL vs HIMS
growth of $100 · dividends reinvested · last 2yGRAL +1028.0% (+235.9%/yr)HIMS +25.3% (+11.9%/yr)GRAL compounded faster over this window
Log scale — wide-divergence pair
GRAL HIMS
GRAL vs HIMS: by the numbers
- •HIMS is the larger company ($6.59B vs $6.06B market cap).
- •Both run net losses; HIMS's is the smaller (-5.51% vs -236.95% net margin).
Metrics side by side
Valuation
| Metric | GRAL | HIMS |
|---|---|---|
| P/S ratio | 36.67 | 2.56 |
| P/B ratio | 2.38 | 20.35 |
| FCF yield | N/A | 1.36% |
Profitability
| Metric | GRAL | HIMS |
|---|---|---|
| Gross margin | -42.52% | 73.84% |
| Operating margin | -362.95% | 4.50% |
| Net margin | -236.95% | -5.51% |
| ROE | -15.40% | -43.83% |
| ROIC | -20.26% | -4.30% |
Growth (annualized)
| Metric | GRAL | HIMS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 67.47% |
| Total return CAGR (5Y) | N/A | 32.23% |
Go deeper
Dig into the metrics
GRAIL ROEHims & Hers Health ROEGRAIL operating marginHims & Hers Health operating marginGRAIL revenue growthHims & Hers Health revenue growthGRAIL free cash flowHims & Hers Health free cash flow
GRAIL & Hims & Hers Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.